Sirtris, a GSK Company

Quick facts

Phase 1 pipeline

• Cap SRT2104
• Carbon-14 radio-labeled SRT2104
• SRT2379
• SRT3025
• SRT501
• Tab SRT2104 fast release
• Tab SRT2104 intermediate release
• Tab SRT2104 slow release

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Sirtris, a GSK Company portfolio CI brief
• Sirtris, a GSK Company pipeline updates RSS

Related

• Sector hub: All tracked pharma companies